Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Ovarian Neoplasms 4Colorectal Neoplasms 3Peritoneal Neoplasms 2Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Melanoma 1Endometrial Neoplasms 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1Breast Neoplasms 1

Interventions

Paclitaxel 8Filgrastim 8Carboplatin 8Peripheral Blood Stem Cell Transplantation 6Ifosfamide 6Etoposide 4Temozolomide 3pembrolizumab 2pegfilgrastim 2ixabepilone 2etoposide phosphate 2Thiotepa 2Melphalan 2Gemcitabine 2Cisplatin 2Amifostine 2sodium thiosulfate 1regorafenib 1carboxyamido-triazole 1aflibercept 1Trabectedin 1Topotecan 1Taxes 1Surveys and Questionnaires 1Restraint, Physical 1Radiotherapy 1Quality of Life 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1PT-100 dipeptide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Folfox protocol × Gynecologic × Clear all
NCT06840886 2026-05-14

A Study of PHST001 in Advanced Solid Tumors

Pheast Therapeutics

Phase 1 Recruiting
272 enrolled
CNSGastrointestinalGynecologic

Ovarian Neoplasms, Central Nervous System Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡